New Delhi, 23 Nov 2024: India’s drug regulator has drastically advanced timelines and tightened guidelines for reporting harmful effects of experimental drugs and treatments in efforts to improve oversight of the country’s pharmaceutical industry.

Companies......
View Details

Related News

• Illegal cough syrup worth Rs 5 Crore seized at Assam-Tripura border (08-12-2024)

---

• Tragedy at Hyderabad Pharma: NGT Orders Accountability (08-12-2024)

---

• Experts Call for Urgent Standardisation and Quality Control of Herbal Medicines (08-12-2024)

---

• Experts Warn Against OTC Creams for Skin Issues: Potential Harm from Steroid Use (08-12-2024)

---

• Expert team will probe maternal deaths in Ballari hospital: Health Minister (08-12-2024)

---

• Maha FDA finds spurious drugs at rural GMCH in Beed, FIR against 4 suppliers (08-12-2024)

---

• CDSCO waives local clinical trials for new drugs approved in the USA, UK, Japan, Australia, Canada and EU: Govt in LS (07-12-2024)

---

• NDPS Act: SC explains law on presence of gazetted officer during search (07-12-2024)

---

• Contraband cough syrup seized from Tejas Rajdhani express (07-12-2024)

---

• Government has taken several measures to encourage domestic manufacturing: Govt in LS (07-12-2024)

---